LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386 | -19.9% | 6,449 | -3.6% | 0.00% | -25.0% |
| Q2 2023 | $482 | -1.8% | 6,690 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $491 | +2.1% | 6,678 | -7.2% | 0.00% | 0.0% |
| Q4 2022 | $481 | -99.9% | 7,200 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $620,000 | -6.3% | 7,200 | -2.9% | 0.01% | 0.0% |
| Q2 2022 | $662,000 | -20.1% | 7,416 | +0.6% | 0.01% | 0.0% |
| Q1 2022 | $829,000 | -65.4% | 7,370 | -52.5% | 0.01% | -33.3% |
| Q4 2021 | $2,396,000 | +117.8% | 15,514 | +96.6% | 0.01% | 0.0% |
| Q3 2021 | $1,100,000 | -30.9% | 7,893 | -34.9% | 0.01% | -30.8% |
| Q2 2021 | $1,591,000 | +376.3% | 12,131 | +452.9% | 0.01% | 0.0% |
| Q1 2021 | $334,000 | +40.3% | 2,194 | -8.4% | 0.01% | +44.4% |
| Q4 2020 | $238,000 | +5.3% | 2,395 | +1.0% | 0.01% | -10.0% |
| Q3 2020 | $226,000 | -17.5% | 2,371 | -3.2% | 0.01% | -23.1% |
| Q2 2020 | $274,000 | +32.4% | 2,449 | -14.2% | 0.01% | +160.0% |
| Q1 2020 | $207,000 | -32.6% | 2,853 | -3.0% | 0.01% | -16.7% |
| Q4 2019 | $307,000 | +0.7% | 2,941 | -4.0% | 0.01% | 0.0% |
| Q3 2019 | $305,000 | -14.3% | 3,064 | -1.9% | 0.01% | -25.0% |
| Q2 2019 | $356,000 | -16.2% | 3,123 | -7.6% | 0.01% | -20.0% |
| Q1 2019 | $425,000 | -4.5% | 3,381 | +3.2% | 0.01% | -23.1% |
| Q4 2018 | $445,000 | +11.8% | 3,276 | +126.1% | 0.01% | +30.0% |
| Q3 2018 | $398,000 | -43.8% | 1,449 | -57.6% | 0.01% | -41.2% |
| Q2 2018 | $708,000 | +44.8% | 3,417 | +15.5% | 0.02% | +30.8% |
| Q1 2018 | $489,000 | +18.7% | 2,959 | -1.6% | 0.01% | +18.2% |
| Q4 2017 | $412,000 | +7.3% | 3,008 | +6.6% | 0.01% | -8.3% |
| Q3 2017 | $384,000 | +12.6% | 2,822 | +0.4% | 0.01% | +9.1% |
| Q2 2017 | $341,000 | +27.7% | 2,812 | +11.6% | 0.01% | -15.4% |
| Q1 2017 | $267,000 | +3.9% | 2,520 | -0.2% | 0.01% | +8.3% |
| Q4 2016 | $257,000 | +14.7% | 2,525 | +14.9% | 0.01% | -7.7% |
| Q3 2016 | $224,000 | -10.8% | 2,198 | +0.4% | 0.01% | -13.3% |
| Q2 2016 | $251,000 | – | 2,190 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |